DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 139 filers reported holding DIPLOMAT PHARMACY INC in Q3 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $78,000 | -18.8% | 19,575 | +0.1% | 0.00% | -50.0% |
| Q3 2019 | $96,000 | -18.6% | 19,547 | +0.5% | 0.00% | 0.0% |
| Q2 2019 | $118,000 | +4.4% | 19,447 | +0.1% | 0.00% | 0.0% |
| Q1 2019 | $113,000 | -56.7% | 19,426 | +0.1% | 0.00% | -60.0% |
| Q4 2018 | $261,000 | -0.4% | 19,408 | +43.8% | 0.01% | +25.0% |
| Q3 2018 | $262,000 | +0.4% | 13,500 | +32.4% | 0.00% | 0.0% |
| Q2 2018 | $261,000 | – | 10,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |